Epistaxis
Epistaxis
Explore linked clinical trials. Standard reference: MESH:M000760115 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effect of Vitamin C Administration on Intraoperative Bleeding in Patients Undergoing Sinusoscopy | Blood Loss, Surgical, Epistaxis, Hemorrhage, Intraoperative Complications, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, chronic rhinosinusitis, nasal disorder, otorhinolaryngologic disease, respiratory system disorder | Not yet recruiting | Phase 2 | 2026-10-08 | NCT07866274 | |
| A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT) | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epistaxis, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, cardiovascular disorder, hematologic disorder, hemorrhagic disease, hereditary hemorrhagic telangiectasia, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, telangiectasis, vascular disorder, vascular hemostatic disease, vascular malformation | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT06659640 | |
| Topical TOR-582 Treatment of Epistaxis in HHT | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epistaxis, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, cardiovascular disorder, hematologic disorder, hemorrhagic disease, hereditary hemorrhagic telangiectasia, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, telangiectasis, vascular disorder, vascular hemostatic disease, vascular malformation | Not yet recruiting | Phase 1 | 2026-08-21 | NCT07667413 | |
| Comprehensive HHT Outcomes Registry of the United States (CHORUS) | Arteriovenous Malformations, Cerebral, Cardiovascular Abnormalities, Central Nervous System Vascular Malformations, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Epistaxis, Gastrointestinal Hemorrhage, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, arteriovenous hemangioma/malformation, arteriovenous malformations of the brain, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system malformation, cerebrovascular disorder, digestive system disorder, hematologic disorder, hemorrhagic disease, hereditary hemorrhagic telangiectasia, intracranial arterial disease, nasal disorder, nervous system disorder, otorhinolaryngologic disease, respiratory system disorder, telangiectasis, vascular disorder, vascular hemostatic disease, vascular malformation | Recruiting | Not stated | 2026-07-17 | NCT06259292 | |
| Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epistaxis, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, cardiovascular disorder, hematologic disorder, hemorrhagic disease, hereditary hemorrhagic telangiectasia, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, telangiectasis, vascular disorder, vascular hemostatic disease, vascular malformation | Recruiting | Not applicable | 2026-07-10 | NCT05641142 | |
| Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Epistaxis, Gastrointestinal Hemorrhage, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, angiodysplasia, blood coagulation disease, blood platelet disease, cardiovascular disorder, coagulation protein disease, digestive system disorder, hematologic disorder, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, vascular disorder, von Willebrand disease (hereditary or acquired) | Recruiting | Not applicable | 2026-05-18 | NCT06651255 | |
| Outcome of Hyaluronic Acid Gel Versus Petroleum Jelly in Treatment of Epistaxis | Epistaxis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, nasal disorder, otorhinolaryngologic disease, respiratory system disorder | Not yet recruiting | Not applicable | 2026-04-22 | NCT07531472 | |
| The Efficacy of Local Application of B-sitosterol Versus Vasline in Cases of Idiopathic Epistaxis | Epistaxis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, nasal disorder, otorhinolaryngologic disease, respiratory system disorder | Not yet recruiting | Phase 4 | 2026-04-15 | NCT07511192 | |
| Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epistaxis, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, anemia, cardiovascular disorder, hematologic disorder, hemorrhagic disease, hereditary hemorrhagic telangiectasia, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, telangiectasis, vascular disorder, vascular hemostatic disease, vascular malformation | Active, not recruiting | Phase 2 / Phase 3 | 2026-03-19 | NCT03850964 | |
| Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epistaxis, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, cardiovascular disorder, hematologic disorder, hemorrhagic disease, hereditary hemorrhagic telangiectasia, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, telangiectasis, vascular disorder, vascular hemostatic disease, vascular malformation | Recruiting | Phase 2 | 2026-03-11 | NCT04976036 | |
| Management of Epistaxis Comparing Nasal Packing Versus Greater Palatine Foramen Block | Epistaxis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, nasal disorder, otorhinolaryngologic disease, respiratory system disorder | Not yet recruiting | Not applicable | 2026-02-24 | NCT07421622 | |
| Usage of Orange Peel Extract in Management of Epistaxis | Epistaxis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, nasal disorder, otorhinolaryngologic disease, respiratory system disorder | Not yet recruiting | Not applicable | 2025-02-20 | NCT06836102 | |
| Adrenaline Nasal Pack vs Xylometazoline Nasal Drops During Nasotracheal Intubation | Epistaxis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, nasal disorder, otorhinolaryngologic disease, respiratory system disorder | Recruiting | Phase 2 / Phase 3 | 2025-01-30 | NCT06801522 | |
| Risk Factors of Epistaxis Recurrence in Adults | Epistaxis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, nasal disorder, otorhinolaryngologic disease, respiratory system disorder | Not yet recruiting | Not stated | 2024-10-24 | NCT06657053 | |
| Medico-economic Evaluation of Management Strategies for Severe Epistaxis | Epistaxis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, nasal disorder, otorhinolaryngologic disease, respiratory system disorder | Recruiting | Not applicable | 2023-08-29 | NCT05281952 |